-
–Neutral fats
–90% of all lipids in the body
Triglycerides
-
–Helps with plasma membrane building
Phosopholipids
-
–Most commonly called cholesterol
–Widely known to cause atherosclerosis
Steroids
-
–Transports cholesterol out of tissues
–AKA good cholesterol
High Density Lipoprotein HDL
-
–Transport cholesterol into the tissues–AKA bad cholesterol
Low Density Lipoproteins (LDL)
-
–Precursor of LDL
–Primary carrier of triglycerides in the blood
- Very low density lipoprotein
- VLDL
-
•Pr: atorvastatin (Lipitor)
•Action: interferes with the synthesis of cholesterol in the liver
•Use: ↓LDL, VLDL, triglyceride levels; ↑HDL
•Adverse effects: HA, fatigue, muscle or joint pain, and heartburn
Statins for reducing blood lipids
-
•Pr: cholestyramine (Questran)
•Action: binds with bile acids in the GI tractto increase excretion of cholesterol in the stool
•Use: ↓LDL levels
•Adverse effects: more SE than statins; GI c/o’s; bloating, constipation, steatorrhea
Bile Acid Resins; Sequesterants for Reducing Blood Lipids
-
•Pr: niacin (B complex vitamin)
•Action: ↓ VLDL level, ∴↓ LDL level
•Use: ↓ VLDL, triglyceride levels; ↑ HDL
•Adverse effects: more SE than statins; flushing (take ASA), hot flashes, N/D, excess gas, hepatotoxicity. Can raise blood glucose in diabetics.
Nicotinic Acid for Reducing Blood Lipids
-
•Pr: gemfibrozil (Lopid)
•Action: unknown, but it ↓ VLDL and ∴ triglycerides, and ↑ HDL
•Use: severe hypertryglyceridemia
•Adverse effects: GI distress, watch for bleeding with clients on anticoagulants
Fibric Acid for Reducing Blood Lipids
-
•Pr: ezetimibe (Zetia)
•Action: inhibits the absorption of cholesterol
•Use: modest reduction of LDL
•Adverse effects: none
Cholesterol Absorption Inhibitors for Reducing Blood Lipids
-
•Assessment
•Nursing Diagnosis–Knowledge deficit regarding condition–Ineffective regimen management–Risk for bleeding
•Planning: the client will:
•Implementation
Nursing Process for Lipid Disorders
-
Cardiovascular Disease (CVD)
- •Includes conditions of heart and blood vessels
- •Hypertension is most common form of CVD
- •Most frequent causes of death in U.S
- •Target organs
- •Disease progression
-
Hypertension: Classified into Three Categories
- •Pre-hypertension
- •Stage 1
- •Stage 2
- •“Normal” B/P at one age; abnormal as we age
-
Goals and Drug Selection of Antihypertensives
•Goal of antihypertensive therapy
•A single drug begins anti-HTN therapy
•Stepped care
•Hypotension (orthostatic) can be caused by ANY drug that alters the BP
-
•Pr: hydrochlorothiazide (Hydrodiuril)
•Action: increase urine output to reduce blood volume to reduce resistance
•Use: mild to moderate HTN
•Adverse effects: electrolyte imbalances, especially potassium
Diuretics for Hypertension
-
•Pr; nifedipine (Procardia)
•Action: prevents Ca from entering muscle, relaxing arterioles (vasodilates)
•Use: hypertension and angina
•Adverse effects: dizziness, HA, flushing, reflex tachycardia. Can become toxic with grapefruit juice (causes greater absorption, causing a greater response.)
Ca Channel Blockers for HTN
-
•Pr; enalapril (Vasotec)
•Action: ACE inhibitors block angiotensin I→II (powerful vasoconstrictor). Also, it decreases reabsorption of Na causing increased urine excretion
•Use: HTN, HF, and MI
•Adverse effects: persistent cough, orthostatic hypotension, angioedema
Angiotensin Converting Enzyme (ACE) Inhibitors for HTN
-
•Pr: losartan potassium (Cozaar)
•Action: blocks angiotensin receptors in arterial smooth muscle (after II is formed)
•Use: HTN
•Adverse effects: hypotension
Angiotensin-Receptor Blockers (ARBs) for HTN
-
•Pr: doxazosin (Cardura)
•Action: blocks affects of sympathetic nervous system leading to vasodilation
•Use: HTN
•Adverse effects: orthostatic hypotension, nausea, bradycardia, dry mouth
•SE are predictable fight or flight
Adrenergic Blockers for HTN
-
•Pr: hydralazine (Apresoline)
•Action: cause vasodilation by direct relaxation of arterial smooth muscle
•Use: severe hypertension and hypertension crisis (2 minute half life)
•Adverse effects: reflex tachycardia, sodium and fluid retention
Direct Vasodilators for HTN
-
•Diuretics–Electrolyte labs, daily weight
•Ca Channel Blockers
•ACE Inhibitors
•Adrenergic Blockers
•Direct Vasodilators
Nursing Considerations for Antihypertensives
-
•Prototype; lisinopril (Prinivil, Zestril)
•Action; enhances excretion of Na & water
•Use; lowers BP and peripheral resistance
•Adverse effects; first-dose hypotension, cough, hyperkalemia, RF6djm6Diuretics
ACE Inhibitors: HF Drug of Choice
-
•Prototype; furosemide (Lasix)
•Action; to increase urine excretion, reducing blood volume (peripheral resistance) and cardiac workload
•Use; reduce edema and pulmonary congestion
•Adverse effects; dehydration, electrolyte imbalance, hypotension, ototoxicity
Diuretics for HF
-
•Prototype; metoprolol (Lopressor, Toprol XL)
•Action; slows the heart rate and ↓ BP resulting in ↓ cardiac workload
•Use; to reduce symptoms of HF and slow progression of disease
•Adverse effects; fluid retention, worsening of HF, fatigue hypotension, bradycardia, heart block
Beta Adrenergic Blockers for HF
-
•Prototype; isosorbide dinitrate (Isordil)
•Action; Directly relax blood vessels and ↓BP resulting in ↓preload, and ↓workload
•Use; to lower BP, especially for those who cannot take ACE Inhibitors
•Adverse effects; reflex tachycardia, orthostatic hypotension
Vasodilators for HF
-
•Prototype; digoxin (Lanoxin)
•Actions; a more forceful, slow heart beat
•Use; increase the contractility or strength of myocardial contraction
•Adverse effects; Narrow margin of safety, dysrhythmias, digitalis toxicity, visual #s
Cardiac Glycosides for HF
-
•Prototype; milrinone (Primacor)
•Action; positive inotrope, blocks enzyme phosphodiesterase in cardiac and smooth muscle, and ↑ contractility
•Use; a short-term therapy for HF
•Adverse effects; Very toxic, hypokalemia, hypotension, supra and ventricular dysrhythmias11djm11Nursing
Phosphodiesterase Inhibitors for HF
-
•Prototype drug:nitroglycerin (Nitrostat)
•Action:potent coronary artery vasodilator
•Use:for lowering myocardial oxygen demand
•Adverse effects:hypotension, dizziness, blurred vision, dry mouth, headache17djm17Beta
Nitrates for Angina
-
•Prototype drug:atenolol (Tenormin)
•Action:slows rate and reduces contractility to reduce cardiac workload
•Use:for prophylaxis of chronic angina
•Adverse effects:hypotension, dizziness, fatigue during exercise18djm18Calcium
Beta Adrenergic Blockers for Angina
-
•Prototype drug:diltiazem (Cardizem)
•Action:relax coronary arteries (dilate) to reduce cardiac workload
•Use:for lowering blood pressure
•Adverse effects:hypotension, bradycardia, heart failure, constipation
Calcium Channel Blockers for Angina
-
•Prototype drug:reteplase (Retavase)
•Action:to dissolve clots obstructing coronary arteries
•Use:for restoring circulation to myocardium
•Adverse effects:excessive bleeding21djm21Other
Thrombolytics for MI
-
•Prototype drug:procainamide (Pronestyl)
•Action:Blocks Na channels, therefore slowing conduction of stimulus
•Use:to correct atrial and ventricular dysrhythmias
•Adverse effects:can create new dysrhythmias or worsen existing ones–Lupus effect, NV, abdominal pain, headache–High doses can produce CNS effects29djm29Beta
Sodium Channel Blockers(Class I)
-
•Prototype drug:propranolol (Inderal)
•Action:to block beta receptors, which ↓HR, conduction velocity& automaticity
•Use:atrial dysrhythmias associated with HF
•Adverse effects:bradycardia, hypotension with dizziness and fainting–Bronchospasms, hypoglycemia, diminished libido
Beta-adrenergic Blockers (Class II)
-
•Prototype drug:amiodarone (Cordarone)
•Action:blocks potassium channels in myocardial cells, which prolongs duration (refractory period) of action potential (slows)
•Use:to treat resistant ventricular tachycardia, atrial dysrhythmias with HF
•Adverse effects:blurred vision, pneumonia-like syndrome, bradycardia, hypotension–Can create new dysrhythmias or worsen existing ones–Restricted use because of serious SE
Potassium Channel Blockers (Class III)
-
•Prototype drug:verapamil (Calan)
•Action:to block calcium-ion channels, which reduces automaticity of the SA node and slows impulse through AV node
•Use:to treat supraventricular tachycardia
•Adverse effects:bradycardia, hypotension, headache
Calcium Channel Blockers (Class IV)
-
•Prototype drugs:heparin (parenteral) and warfarin (Coumadin) (po) (LMWH: low molecular weight heparins)
•Action:to inhibit platelet aggregation (“clumping”) to ↓formation or enlargement of clots (do not “thin” blood)
•Use:to prevent thrombi from forming or enlarging, prevent formation of clots in veins, treat thromboembolic disorders
•Adverse effects:abnormal bleeding
Parenteral and Oral Anticoagulants
-
•Prototype drug:(ADP receptor blocker) clopidogrel (Plavix)
•Action:platelets do not aggregate (clot)
•Use:to prevent thrombi formation after a stroke (CVA) or myocardial infarction (MI)
•Adverse effects:abnormal bleeding
Antiplatelet Aggregate Drug for Anticoagulants
-
•Prototype drug:aminocaproic acid (Amicar)
•Action:to prevent fibrin from dissolving clots
•Use:To promote formation of clots by preventing and treating excessive bleeding from surgical sites, therefore shortens bleeding time
•Adverse effects:May cause hyper-coagulation (clots) with concurrent use of estrogens and oral contraceptives45Nursing
Hemostatics (Antifibrinolytics) Drugs that Promote the Formation of Clots
-
•Prototype drug: erythropoietin, epoetin alpha (Epogen, Procrit)
•Action: hormone secreted by kidneys, sends message to bone marrow to increase erythrocyte production
•Use: treatment of anemia
•Adverse effects: hypertension, seizures
•Nursing cons: HTN, thromboembolism, H/H
Hematopoetic growth factor
-
•Prototype drug: filgrastim (Neupogen)
•Action: to increase neutrophil production
•Use: chemo, organ transplant, AIDS complications, severe bacterial infections
•Adverse effects: bone pain, allergies, thrombocytopenia
•Nursing cons: WBC levels, not given within 24 hours of chemo. Report dyspnea, tachycardia, and low BP
Colony stimulating factors
-
•Pr: oprelvekin (Neumega): only drug in this class
•Action: Stimulates thrombopoeitin to increase production of platelets
•Use: chemo pts with thrombocytopenia
•Adverse effects: fluid retention
•Nursing cons: do not give within 24 hours of chemo
Platelet enhancers
-
•Prototype drug: cyanocobalamin (Crystamine, vitamin B12, others)
•Action: to replace vitamin B12
•Use: treatment of vitamin B12 deficiency
•Adverse effects: diarrhea, hypokalemia, rash, anaphylaxis
•Nursing cons: stools may be dark green or black
Pernicious Anemia
-
•Prototype drug:ferrous sulfate (Feosol)
•Action:to supplement iron needed by body
•Use:to treat iron deficiency
•Adverse effects:–Nausea, heartburn, constipation, dark stools
•Nursing cons: give 1 hour before or 2 hours after a meal, take as directed since excessive doses can be toxic
Iron deficiency anemia
-
•Prototype drug: normal serum albumin (Albuminar, Albutein)
•Action: to maintain plasma osmotic pressure and transport substances through blood
•Use: restoration of plasma volume and blood proteins
•Adverse effects: allergies and protein overload
Colloid
-
•Pr: norepinephrine (Levaterenol, Levophed)
•Action: to act directly on alpha-adrenergic receptors to raise blood pressure; also has positive inotropic effects
•Use: treat acute shock and cardiac arrest
•Adverse effects: tachycardia, bradycardia, and hypertension
Sympathomimetics
-
•Prototype drug: dopamine (Dopastat, Inotropin)
•Action: is dose dependent; low doses = dopaminergic effect, high doses = beta-adrenergic effect
•Use: to treat septic and cardiogenic shock
•Adverse effects: dysrhythmias, hypertension, gangrene
Inotropics (Cardiotonic Agents)
-
•Prototype drug: epinephrine (Adrenalin)
•Action: for use as nonselective adrenergic agonist
•Use: to treat anaphylaxis, shock, cardiac arrest
•Adverse effects: hypertension and dysrhythmias
Sympathomimetic/ Anaphylaxis
-
•Prototype; furosemide (Lasix)
•Action: Block reabsorption of Na in loop
•Uses: treat HTN, Moderate to severe fluid retention from HF, hepatic cirrhosis, RF
•Adverse effects: rapid, large excretion of urine, dehydration and electrolyte imbalances, ototoxicity
pharmacotherapy with loop diuretics
-
•Prototype; chlorothiazide (Diuril)
•Action: Block reabsorption of sodium, in distal tubule, increasing urine excretion
•Uses: Mild to moderate hypertension
•Adverse effects: Dehydration, orthostatic hypotension, hypokalemia
pharmacotherapy with thiazide diuretics
-
•Prototype: spironolactone (Aldactone)
•Action: blocks aldosterone by not reabsorbing Na (and water) and not excreting K
•Use: mild diuresis in HF •Adverse effects: hyperkalemia
pharmacotherapy with potassium sparring diuretics
-
•Prototype; dextran 40
•Action: raise oncotic pressure of blood, therefore pulling water and expanding plasma volume within minutes
•Use: fluid replacement for hypovolemia D/T hemorrhage, surgery, severe burns
•Adverse effects: hypersensitivity reactions fluid overload, HTN
IV fluid therapy with Colloids
-
•Prototype; Sodium chloride (NaCl)
•Major electrolyte in ECF
•Connected to water balance: water travels toward or with Na
•Regulation of Na output is important function of kidneys
•Hypernatremia: Na level > 145 mEq/L
•Hyponatremia: Na level < 135 mEq/L
pharmacotherapy of sodium imbalances
-
•Prototype; potassium chloride
•Most abundant electrolyte in ICF
•Renal excretion closely linked with that of sodium
•Hyperkalemia: K level > 5 mEq/L
•Hypokalemia: K level < 3.5 mEq/L
pharmacotherapy of potassium imbalances
-
•Prototype; potassium chloride
•Most abundant electrolyte in ICF
•Renal excretion closely linked with that of sodium
•Hyperkalemia: K level > 5 mEq/L
•Hypokalemia: K level < 3.5 mEq/L
pharmacotherapy of acidosis
-
•Prototype; ammonium chloride•Alkalosis develops at pH values > 7.45•Symptoms; nervousness, hyper reflexes, convulsions: slow, shallow respirations to retain CO2•Causes;–Respiratory: hyperventilation (asthma, anxiety)–Metabolic: prolonged constipation, excess sodium bicarbonate, potassium depleting diuretics, severe vomiting
Pharmacotherpay of alkalosis
|
|